CYRX - CryoPort Chief Scientific Officer Acquires 1000 Shares After Exercising Company Stock Options | Benzinga
Mark Sawicki, Chief Scientific Officer at CryoPort (NASDAQ:CYRX), reported a large exercise of company stock options on September 13, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Sawicki, Chief Scientific Officer at CryoPort, a company in the Health Care sector, just exercised stock options worth 1,000 shares of CYRX stock with an exercise price of $12.79.
CryoPort shares are trading up 3.12% at $15.22 at the time of this writing on Thursday morning. Since the current price is $15.22, this makes Sawicki's 1,000 shares worth $15,220.